Literature DB >> 33315638

COVID in obstetrics: labor analgesia and cesarean section.

Emilia Guasch1, Nicolas Brogly1, Fernando Gilsanz2.   

Abstract

PURPOSE OF REVIEW: This review is based on the latest evidence to provide a good standard of care for COVID-19 parturients and protection to healthcare givers. RECENT
FINDINGS: COVID-19 by itself is not an indication for cesarean section. Different publications demonstrated the efficacy of neuraxial analgesia/anesthesia for delivery. Although SARS-CoV-2 was associated with a certain neurotropism, neuraxial block was not associated with neurological damage in COVID-19 parturients, and seems as safe and effective as in normal situations. It permits to avoid a general anesthesia in case of intrapartum cesarean section. Epidural failure is a concern: it may lead to a general anesthesia in case of emergency cesarean section. Local protocols and well-trained anesthesiologists will be helpful. COVID-19 patients require special circuits and every step (transfer to and from theatre, recovery, analgesia, and so on) should be planned in advance. For cesarean section under general anesthesia, personal protection equipment must be enhanced. Postoperative analgesia with neuraxial opioids, NSAIDs, or regional blocks are recommended. COVID-19 and pregnancy increase the risk of thrombosis, so thromboprophylaxis has to be considered and protocolized.
SUMMARY: Anesthetic care for delivery in COVID-19 parturients should include neuraxial blocks. Special attention should be paid on the risk of thrombosis.

Entities:  

Year:  2020        PMID: 33315638     DOI: 10.1097/ACO.0000000000000949

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  1 in total

Review 1.  Preparation and consideration for establishment of an isolation maternity unit in a tertiary hospital during COVID-19 pandemic.

Authors:  Yingke He; Yvonne Wan Yu Wong; Alvin Jia Hao Ngeow; Eileen Yilin Sim; Benjamin Pei Zhi Cherng; Sridhar Arunachalam; Selina Kah Ying Ho; Wei Ching Tan; Un Sam Mok
Journal:  BMC Pregnancy Childbirth       Date:  2022-04-13       Impact factor: 3.007

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.